Ocular Therapeutix, Inc. · NASDAQ:OCUL

Deep Track Capital, LP reported a 5.13% stake in Ocular Therapeutix, Inc. (Schedule 13G)

Event Feb 5, 2026 · Filed Feb 10, 2026

Deep Track Capital, LP reported a 5.13% stake in Ocular Therapeutix, Inc., 11,234,132 shares, as a passive investor on Feb 5, 2026. Filed Feb 10, 2026 (Schedule 13G).

Stake
5.13%
Shares
11,234,132
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.13%11,234,132
Deep Track Biotechnology Master Fund, Ltd.5.13%11,234,132
David Kroin5.13%11,234,132

Source

View original at SEC

Related